![Jian Li](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jian Li
Direttore/Membro del Consiglio presso Shanghai Drug Farm Biological Technology Co., Ltd.
Posizioni attive di Jian Li
Società | Posizione | Inizio | Fine |
---|---|---|---|
Shanghai Drug Farm Biological Technology Co., Ltd.
![]() Shanghai Drug Farm Biological Technology Co., Ltd. Information Technology ServicesTechnology Services Shanghai Drug Farm Biological Technology Co., Ltd. is a Chinese private biotechnology company that focuses on developing innovative treatments for hepatitis B, heart and kidney diseases, and ROSAH syndrome. The company utilizes breakthrough technologies in genetics and AI to discover new treatments through its unique IDinVivo platform. This platform allows the direct assessment of gene targets in living animals with intact immune systems, which has led to the identification of novel innate immunity pathways and targets. Drug Farm is now advancing multiple first-in-class drug candidates into clinical development. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Jian Li
Statistiche
Distribuzione geografica
Cina | 2 |
Posizioni
Director/Board Member | 1 |
Settori
Technology Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Shanghai Drug Farm Biological Technology Co., Ltd.
![]() Shanghai Drug Farm Biological Technology Co., Ltd. Information Technology ServicesTechnology Services Shanghai Drug Farm Biological Technology Co., Ltd. is a Chinese private biotechnology company that focuses on developing innovative treatments for hepatitis B, heart and kidney diseases, and ROSAH syndrome. The company utilizes breakthrough technologies in genetics and AI to discover new treatments through its unique IDinVivo platform. This platform allows the direct assessment of gene targets in living animals with intact immune systems, which has led to the identification of novel innate immunity pathways and targets. Drug Farm is now advancing multiple first-in-class drug candidates into clinical development. | Technology Services |
- Borsa valori
- Insiders
- Jian Li
- Esperienza